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Abstract
Background: To assess both qualitatively and quantitatively the impact of Public Reporting (PR) on clinical outcomes,
we carried out a systematic review of published studies on this topic.
Methods: Pubmed, Web of Science and SCOPUS databases were searched to identify studies published from 1991
to 2014 that investigated the relationship between PR and clinical outcomes. Studies were considered eligible if they
investigated the relationship between PR and clinical outcomes and comprehensively described the PR mechanism
and the study design adopted. Among the clinical outcomes identified, meta-analysis was performed for overall
mortality rate which quantitative data were exhaustively reported in a sufficient number of studies. Two reviewers
conducted all data extraction independently and disagreements were resolved through discussion. The same reviewers
evaluated also the quality of the studies using a GRADE approach.
Results: Twenty-seven studies were included. Mainly, the effect of PR on clinical outcomes was positive. Meta-analysis
regarding overall mortality included, in a context of high heterogeneity, 10 studies with a total of 1,840,401 experimental
events and 3,670,446 control events and resulted in a RR of 0.85 (95 % CI, 0.79-0.92).
Conclusions: The introduction of PR programs at different levels of the healthcare sector is a challenging but rewarding
public health strategy. Existing research covering different clinical outcomes supports the idea that PR could, in fact,
stimulate providers to improve healthcare quality.
Keywords: Public reporting, Healthcare quality, Clinical outcomes, Systematic review
Background
Public reporting (PR) is a mechanism of “providing
data about a health care structure, process, or outcome
publicly available or available to a broad audience free
of charge or at a nominal cost, in order to be able to
compare data across providers or to a national/regional
data report on performance for which there are accepted
standards or best practices” [1]. Public release of quality
and clinical performance of the healthcare providers is
becoming increasingly common among the healthcare sys-
tems worldwide. Policy and decision-makers in a demand-
driven healthcare system are becoming more interested in
having information about quality performance [2] and
thereby PR has been proposed as a mechanism for
providing more transparency and accountability of
healthcare providers [3]. Constant improvement of the
quality of care should be one of the top priorities of
healthcare providers [4]. According to the theory of PR,
healthcare users are expected to inform themselves about
the quality of healthcare system before selecting the par-
ticular provider and so those with high performance
would be rewarded by selecting, while low performers
would be avoided and thereby stimulated to improve their
performance [5–8].
There have been suggested several pathways through
which quality might be improved after the release of
performance data. First pathway, the selection pathway,
proposed by Berwick et al., is based on the concern of
healthcare providers about their market share, where con-
sumers choosing better performers, motivate providers’ ef-
forts to improve quality in order to attract more patients.
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The change pathway, also proposed by Berwick et al., is
based on the concept that identifying quality deficits is
sufficient to stimulate the professional motivation of
clinicians and organizations to improve [9]. After observ-
ing in their study that these two pathways were a relatively
weak stimulus to action, Hibbard et al., introduced the
third pathway - the reputation pathway, based on the
premise that providers which perform poorly, after being
identified through the PR, suffer damage to their reputa-
tion and further motivate quality improvements in order
to protect or improve reputation [10].
PR of clinical outcomes data is a great tool for increas-
ing the transparency in healthcare which enables patients
to make informed choices about their healthcare. The
most convincing rationale for the PR of clinical outcomes
is the one’s right to be aware of the quality of care that he/
she is likely to receive from providers [11]. Cardiac surgery
has been a pioneer field for the publication of clinical out-
comes, since being among the most frequently performed
complex surgical procedures [12]. The collection and
publication of standardized military hospital mortality
rates by Florence Nightingale in 1863 where highlighting
the differences in mortality rates between hospitals is be-
lieved to be the earliest attempt of PR of clinical outcome
and in general [13]. The modern practice of PR systems
started in the late 1980s in the USA with the introduction
of Coronary Artery Bypass Graft (CABG) report cards of
New York State Department of Health, as the first state
wide program where the risk adjusted post-operative mor-
tality rates following CABG surgery are being published at
the level of both the hospital and the individual surgeon
resulting in a 41% decline in risk-adjusted CABG mortal-
ity rate [14]. In Europe, back in 1994, Scotland was the
first to adopt PR with the Clinical Resource and Audit
Group (CRAG) [15]. After these initiatives, other coun-
tries have started to follow their example and implement
PR into their healthcare systems.
Several authors, over the years have studied the effects
of PR on clinical outcomes and, still nowadays, there are
inconsistent results in the literature. The review of health-
care PR by Fung et al. found mixed signals among the
studies of the effect of PR on outcomes, with some studies
showing no effects and others showing minimal effects.
Indeed the authors concluded that a solid evidence is still
lacking and the systematic evaluation of many major PR
systems is needed [5]. The scarcity of a solid evidence does
not necessarily suggests the lack of effect and, since the
publication of Fung et al., many studies have been con-
ducted to explore the effect of public release of perform-
ance data on clinical outcome, but always with incoherent
results. Thus, we took the aim to perform an up-to-date
systematic review of scientific literature in order to
synthesize, both qualitatively and quantitatively, the im-
pact of PR on clinical outcomes.
Methods
A protocol was developed and a systematic review
and a meta-analysis were conducted and reported in
accord with PRISMA guidelines for meta-analyses and
systematic reviews [16].
Search strategy and study selection
A literature search was performed by accessing Pubmed,
Thomson Reuters Web of Science and Scopus databases to
identify studies that investigated the relationship between
PR and clinical outcomes. The search terms “public report-
ing”, “quality reporting”, “information dissemination”, “data
shar*” and “report card*” were used, by specifying “health”
for databases that also covered non-health topics.
Our search was restricted to English language studies
published from 1st January 1991 to 31st December 2014.
Studies were considered eligible if they comprehensively
described the PR mechanism in terms of subjects, set-
ting, location and dissemination way, if the study design
adopted was clearly described and if they investigated
the relationship between PR and clinical outcomes. Stud-
ies not reporting original data as well as studies focusing
only on non-clinical effects of PR were excluded.
Two reviewers independently screened titles and identi-
fied abstracts of relevant titles. Full texts of potential ci-
tations were subsequently obtained and independently
screened by the two reviewers for inclusion. Disagree-
ments were resolved through discussion. Additional rele-
vant publications were identified from the references of
the initially retrieved articles.
Data extraction and analysis
From each study data on the first author’s last name,
year of publication, objective, subject, setting, location,
PR mechanism, clinical outcome assessed and key find-
ings were extracted. For each clinical outcome assessed,
quantitative data were also extracted if available.
Two reviewers conducted all data extraction inde-
pendently and disagreements were resolved through
discussion. The same reviewers evaluated also the qual-
ity of the studies using a GRADE derived approach (see
Additional file 1) [17].
Among the clinical outcomes evaluated, meta-analysis
was performed for overall mortality rate which quantita-
tive data were exhaustively reported in 10 different stud-
ies. Because of the significant heterogeneity expected
among the studies performed in different settings, the
random effects model was employed using the Der
Simonian and Laird’s method [18].
Heterogeneity was quantified using the Cochran Q
test and I2 statistics [19] and subgroup analyses were
performed for different study design and setting.
Sensitivity analyses were conducted by excluding one
study at a time from the meta-analysis to determine
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whether the results of the meta-analysis were influ-
enced by individual studies and whether risk estimates
and heterogeneity were substantially modified.
The presence of publication bias was assessed using
the Egger’s test [20].
All analyses were carried out using Review Manager,
version 5.2.7 for Mac (The Nordic Cochrane Centre,
Copenhagen, Denmark) and Stata, version 13.1 for Mac
(StataCorp, College Station TX, USA).
Results
Characteristics of the studies
We identified a total number of 22,404 studies through
Pubmed, Thomson Reuters Web of Science, Scopus
online databases search. After removing the duplicates,
10,578 studies were left, and, carefully reading the titles,
2,145 studies were assessed for eligibility. Further step
was reviewing the abstracts, and 254 full text articles
were obtained. By not fulfilling the inclusion criteria,
231 full text articles were excluded, and 4 were individu-
ated from the screening of references list of studies that
fulfilled inclusion criteria, leaving 27 studies to be in-
cluded in our analysis [14, 21–46]. Figure 1 depicts the
process of literature search and study selection.
The publication years of the studies were ranged from
1994 [21] until the most recent ones, from 2014 [44–46].
Most of the 27 studies included in our review (N = 23)
were carried out in the US [14, 21–30, 32–39, 41–44], one
in Canada [31] and Italy [40], and the remaining two in
China [45, 46]. Twelve were cohort studies in which the
6,543 of records 
identified through 
Pubmed searching
8,032 of records 
identified through 
Scopus searching
10,578 of records after removing the duplicates
10,578 of records screened at title 
review
254 of full text articles assessed for 
eligibility
27 of studies of clinical outcome included 
in the qualitative synthesis
8,433 of records excluded
231 of full-text articles 
excluded
2,145 of records screened at abstract 
review
1,891 of records excluded
7,829 of records 
identified through Web 
of Science searching
23 of studies of clinical outcome 
included in the qualitative synthesis
4 records added after 
screening the references list 
of the included studies
Fig. 1 Flowchart depicting literature search and study selection
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control and study cohorts of patients were taken from
different facilities over the same period of time [23, 26, 29,
33, 35, 38, 39, 42–46], 14 were cohort studies in which the
control and study cohorts of patients were taken from the
same facilities before and after the introduction of a PR
mechanism [14, 21, 22, 24, 25, 27, 28, 30–32, 34, 36, 37,
41], while the remaining study used both cohort designs
[40]. The majority of the studies included in this review
presented performance information in the form of “report
cards”, while the others used different forms to communi-
cate data to the public (Table 1).
There were several clinical outcomes examined through-
out the studies. Many investigated the effect of PR on pa-
tients’ mortality [14, 21–33, 35–39, 41, 43, 44]. Other aims
in these studies included investigation of cardiac readmis-
sion to hospital [28, 37], antibiotic use, and waiting times
to see a physician [34], injection prescribing rates [45],
Percutaneous Coronary Intervention (PCI) rates, hip frac-
tures operated on within 48 h, cesarean deliveries [40],
change in CABG operations volume [14], improvements
in infection prevention [42] and patient choices [36].
We included a total number of 27 studies in our sys-
tematic review that evaluated the effect of PR on clin-
ical outcomes and the results are summarized in
Table 1. Mainly, the effect of PR on clinical outcomes
was positive. Fourteen studies reported positive results
[14, 21–23, 25, 30–33, 36, 37, 40, 44, 45], nine reported
not significant results [26, 27, 29, 34, 35, 38, 41–43],
three studies reported mixed results [24, 39, 46], some
positive and some negative or null, while one study re-
ported a negative effect [28].
We used a GRADE derived approach to assess the
quality of the included studies. The body of evidence in
our review was characterized by a low quality level (see
Additional file 1). Indeed, the study design was, in
almost all of the studies, observational, and there were
a number of limitations. When a pre-post approach at
hospital level was used to assess the performance
before and after the release of PR, there was no external
control group for comparison. Moreover, there was no
information on institutions and participants that were
lost-to-follow-up during the study period. Also, the dif-
ferent outcomes, for institutions with and without PR,
could be influenced by some characteristics not mea-
sured across the studies.
Effects of public reporting on mortality
The effect of PR on mortality, as isolated clinical outcome,
was evaluated throughout 22 studies [14, 21–33, 35–39,
41, 43, 44]. All studies were set in hospitals, in the US and
Canada, and 19 of them were on cardiac patients and used
PR data mostly from specific CSRS. A positive effect of PR
on mortality was reported in 12 studies [14, 21–23, 25,
30–33, 36, 37, 44].
Two studies reported mixed effect of the PR on
patients’ mortality. Baker et al. [24] demonstrated that,
for most conditions, after the release of PR, risk-
adjusted in-hospital mortality declined and mortality
rate in the early post discharge period rose, while the
30-day mortality rate declined for heart failure and ob-
structive pulmonary disease and increased for stroke,
while Joynt et al. [39] stated no differences in reporting
versus non reporting states for overall mortality among
patients with acute myocardial infarction (AMI), except
among Medicare beneficiaries with AMI [39].
The only study in our review that reported a negative ef-
fect of PR was a cohort study from Dranove et al. [28],
where the authors showed a statistically marginal evidence
that after releasing the report cards, the average mortality
rate in New York and Pennsylvania hospitals performing
CABG increased by 0.45 percentage point on a base of
33 %. The remaining 7 studies reported non-significant
effect of PR on mortality [26, 27, 29, 35, 38, 41, 43].
Ten out of the 22 studies investigating mortality as an
outcome [22, 23, 26, 28–31, 38, 39, 41] reported sufficient
quantitative data to be pooled through meta-analysis.
Overall, this analysis included a total of 1,840,401 experi-
mental events and 3,670,446 control events. The meta-
analysis resulted in a RR of 0.85 (95 % CI, 0.79-0.92) in a
contest of high heterogeneity (p ≤ 0.0001; I2 = 99.1 %)
(Fig. 2). Publication bias was not evident using the Egger’s
test (p = 0.91). We also performed a one-way sensitivity
analysis, where one by one study was omitted from the
overall meta-analysis, but no significant change in risk
estimates was noticed.
A subgroup analysis on mortality by study design
was also carried out. The six publications [22, 23, 28,
30, 31, 41] reporting mortality rates in the same facil-
ities during different periods showed a RR of 0.85
(95 % CI, 0.76-0.94) in a context of high heterogen-
eity (p < 0.0001; I2 = 100 %). Whilst, the four included
studies [26, 29, 38, 39] recording mortality rates dur-
ing the same period in different facilities showed a
RR of 0.91 (95 % CI, 0.85-0.97) in a context of high
heterogeneity I2 = 95 % (p < 0.0001) (Fig. 2). Test for
subgroup differences resulted negative with a p value
of 0.28.
Another subgroup analysis was performed by studies
considering different mortality causes. Pooling the results
from studies focused on mortality from cardiovascular
disease, six studies were included [23, 28–31, 39] and a
RR of 0.83 (95 % CI, 0.77-0.91) was calculated, with
high heterogeneity (p < 0.0001; I2 = 95 %). For the sub-
group of studies that included patients with a wide
range of conditions [22, 26, 38, 41], a RR of 0.91 (95 % CI,
0.83-0.99) was obtained, with heterogeneity I2 = 99 % (p <
0.0001) (Fig. 3). Test for subgroup differences resulted
negative with a p value of 0.18.
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Table 1 Characteristics of the included studies and effects of PR on clinical outcomes









To evaluate the impact of
NYS CSRS program in
CABG related mortality in
one hospital identified as
poor performing
Cohort study for the
same facility before and
after the introduction
of a PR mechanism
One poorly performing,
high risk hospital in
New York (1992–1993)
NYS CSRS Cardiac mortality The NYS CSRS program has been associated
with a reduction in the actual CABG-related
mortality from 3.52 % in 1989 to 2.78 % in
1992. The risk-adjusted mortality, using pooled
data from 1989 to 1992, decreased from 4.17 %









during the first 4 years
of NYS CSRS in three
groups of hospitals
Cohort study for the
same facility before and






NYS CSRS Cardiac mortality
and CABG
operation volume
During 4 years of NYS CSRS program, the risk-
adjusted mortality decreased from 2.72 to
2.19 % for group1, from 4.24 to 2.51 % for
group 2 and from 7.12 to 2.77 % for group 3.
The groups of providers that showed the
highest initial mortalities manifested the most
improvement. The volume of operations
performed by the various provider groups did











Cohort study for the
same facility before and









Risk-adjusted mortality for most conditions
declined for 3 subsequent periods after
publication of mortality data (July-December
1992/January-June 1993/ July-December
1993). Decreases in mortality rates were
statistically significant in weighted linear
regression analyses for heart failure (0.50 %





To examine the impact
of the NYS CSRS on
in-hospital mortality rates
by comparing mortality
rates in New York to





same period of time
New York Hospital
Medicare beneficiaries




NYS CSRS Cardiac mortality After NYS CSRS program initiation, unadjusted
30-day mortality rates following bypass declined
by 33 % in NY Medicare patients compared with
a 19 % decline nationwide. Risk-adjusted
30-day mortality of bypass surgery in NY
patients declined an average of 10.30 %
per year (1987–1992) compared with 5.80 %
for patients in the rest of the nation.
Positive
Baker et al., 2002
[24]
To examine mortality





Cohort study for the
same facility before and
after the introduction











During CHQC program risk-adjusted in-
hospital mortality declined for all conditions
except stroke and GIH. The 30-day mortality
declined significantly only for CHF to 1.40 %,
and COPD to 1.60 %. For stroke, risk-adjusted
30-day mortality actually increased by 4.30 %.
Mixed
Chassin, 2002 [25] To examine the impact of
NYS CSRS implementation
on mortality rate outlier
status and CABG mortality
Cohort study for the
same facility before and
after the introduction
of a PR mechanism
Lowest And Highest
CABG Mortality
Hospitals In New York,
(1989–1995)
NYS CSRS Cardiac mortality After NYS CSRS program was implemented risk-
adjusted mortality fell 41 % statewide in New
York. Mortality statewide continued to fall in the
next period; the crude mortality reached 2.15 %

















Table 1 Characteristics of the included studies and effects of PR on clinical outcomes (Continued)
Clough et al., 2002
[26]




















No significant beneficial effect of the CHQC
project on hospital mortality in Cleveland was
demonstrated. The rate of decline in mortality
in Cleveland (−0.218 % per six months) was
statistically indistinguishable from that in the
rest of the state.
None
Baker et al., 2003
[27]
To describe trends in risk-
adjusted mortality for six
acute conditions for hospi-
tals that were identified
as outliers by CHQC com-
pared with other hospitals.
Cohort study for the
same facility before and
after the introduction














Hospital outlier status was not significantly
related to changes in risk-adjusted 30-day
mortality. During CHQC reporting period, the
absolute decline in risk-adjusted 30-day mor-




To study the effects of PR
in New York and
Pennsylvania on health
care providers and patient
outcomes
Cohort study for the
same facility before and
after the introduction
of a PR mechanism
Medicare beneficiaries
and hospitals found in















Report card provided statistically marginal
evidence that the average mortality rate in NY
and PA increased by 0,45 % point on a base
of 33 %. Report cards increased significantly
the average rate of readmission with heart





mortality from large mul-
ticenter PCI databases in
Michigan, where PR is
not mandated, and in
New York where PR of





same period of time









Cardiac mortality The unadjusted in-hospital mortality rate
was significantly lower in New York than in
Michigan (0.83 % vs. 1.54 %, OR = 0.54).
However, after adjustment for comorbidities,
there was no significant difference in mor-
tality between the two groups (adjusted
OR = 1.05).
None
Carey et al., 2006
[30]
To examine the relationship
between CCSIP and cardiac
surgery mortality in
California Hospital
Cohort study for the
same facility before and
after the introduction
of a PR mechanism
Cardiac surgery patients
(CABG, PCI, Valve) in
California Hospital
(1998–2004)
CCSIP Cardiac mortality The risk-adjusted in-hospital mortality for
CABG decreased and PCI mortality remained
unchanged. Combining the two procedural
groups, the average annual mortality was
1.88 % (1998–2002) compared with 1.67 %
(2003–2004)
Positive





during the transition from
no reporting to
confidential, and
ultimately PR cards for
CABG surgery in a public
health system in Ontario
Cohort study for the
same facility before and
after the introduction
of a PR mechanism










Cardiac mortality The risk-adjusted 30-day mortality rate de-
creased 29 % from the era of no reporting
(1991–1993) to confidential reporting
(1994–1998). There was no further decrease
with PR (1999–2001). In-hospital mortality
fell significantly faster in Ontario during the
period of confidential reporting than in

















Table 1 Characteristics of the included studies and effects of PR on clinical outcomes (Continued)
Jha et al., 2006 To examine the impact of
NYS CSRS fifteen years
after its launch on cardiac
surgery mortality
Cohort study for the
same facility before and
after the introduction
of a PR mechanism




NYS CSRS Cardiac mortality Users who picked a top-performing hospital or
surgeon from the latest available report had
approximately half the chance of dying (risk-
adjusted mortality rate = 1.59) as did those who
picked a hospital or surgeon from the bottom




To assess effect of
intensive PHC4 on
















Patients treated at hospitals subjected to
intensive PR had significantly lower odds of in-
hospital mortality when compared with similar
patients treated at hospitals in environments
with no PR or only limited reporting. The 2000–
2003 in-hospital mortality OR for Pennsylvania
patients versus non-Pennsylvania patients
ranged from 0.59 to 0.79 across 6 clinical
conditions. For the same comparison using the












Cohort study for the
same facility before and
after the introduction
of a PR mechanism
Patients with
respiratory symptoms












times to see a
physician
Public reporting of hospital antibiotic timing
scores has not led to increased pneumonia
diagnosis, antibiotic use, or change in patient
prioritization. Comparing outcomes before
and after antibiotic timing score reporting,
there were no differences in rates of
pneumonia diagnosis (10 % vs. 11 %) or
antibiotic administration (34 % vs. 35 %).
None
Ryan, 2009 [35] To evaluate the effects of
the PHQID, a public







same period of time
Medicare patients with
AMI, heart failure,




PHQID program Cardiac and
Respiratory
mortality
No evidence that the PHQID had a significant
effect on risk-adjusted 30-day mortality for AMI,
heart failure, pneumonia, or CABG.
None
Li et al., 2010 [36] To evaluate the impact of
PR by comparing CABG
volume and mortality for
hospitals and surgeons in
the first year of state-
mandated PR (2003), and
with the most recent data
available (2006)
Cohort study for the
same facility before and
after the introduction











Cardiac mortality The statewide observed mortality declined
from 2.90 % in 2003 to 2.22 % in 2006. Overall,
the empiric odds ratio of operative death for
2006 patients was 24 % lower than for 2003
patients. Total CABG volume decreased from
2003 to 2006 by almost 27 %.
Positive
Werner et al., 2010
[37]
To estimate changes in
cardiac and respiratory
mortality, length of stay
and readmission rate after
Hospital Compare was
initiated
Cohort study for the
same facility before and
after the introduction
of a PR mechanism
Patients with AMI, heart
failure, pneumonia






















There was a decline in mortality rates (0.6 %
points), lengths-of-stay (0.19 days), and re-
admission rates (0.5 % points) for acute
myocardial infarction from 2004 to 2006.
Changes in outcomes for heart failure and
pneumonia were less consistent and smaller,

















Table 1 Characteristics of the included studies and effects of PR on clinical outcomes (Continued)
Jha et al., 2012
[38]
To assess the long-term
effect of the Medicare
PHQID on cardiac and re-
spiratory mortality at






same period of time











No evidence that the largest hospital-based pay-
for-performance program led to a decrease in
30-day mortality. The rates of decline in mortality
per quarter at Premier and Non Premier hospi-
tals were also similar (0.04 and 0.04 %, re-
spectively; and mortality remained similar
after 6 years under the pay-for-performance
system (11.82 % for Premier hospitals and
11.74 % for non-Premier hospitals)
None
Joynt et al., 2012
[39]
To evaluate PCI mortality
in PR states versus non-





same period of time
Medicare patients
admitted with acute MI






Cardiac mortality There were no differences in overall mortality
among patients with acute MI in reporting vs
non reporting states. In Massachusetts, odds
of PCI for acute MI were comparable with
odds in non reporting states prior to PR
(40.6 % vs 41.8 %; OR, 1.00). Among Medicare
beneficiaries with acute MI, the use of PCI was
lower for patients treated in states with PR
compared with patients treated in states
without PR
Mixed





and PCI rates, hip
fractures, cesarean
deliveries in Lazio versus
other regions of Italy
Cohort study for the
same facility before and
after the introduction





same period of time















In Lazio PCI within 48 h, changed from 22.49
to 29.43 % following reporting of the
P.Re.Val.E results. In the other regions this
proportion increased from 22.48 to 27.09 %
during the same time period. Hip fractures
operated on within 48 h increased from 11.73
to 15.78 % in Lazio, and not in other regions
(from 29.36 to 28.57 %). Cesarean deliveries
did not decrease in Lazio (from 34.57 to
35.30 %, and only slightly decreased in the
other regions (from 30.49 to 28.11 %).
Positive
Ryan et al., 2012
[41]
To estimate the effect of
Hospital Compare,
Medicare’s PR initiative on
30-day mortality for heart
attack, heart failure, and
pneumonia
Cohort study for the
same facility before and
after the introduction















Hospitals that reported quality data under
Hospital Compare had no reductions in
mortality beyond existing trends for heart attack
and pneumonia and led to a modest reduction
in mortality for heart failure (RR = 0.92)
None
Linkin et al., 2013
[42]
To evaluate the association
between state-legislated PR
of hospital-acquired infec-






same period of time
Patients from 137









There is not estimated improvement in
infection prevention program or hospital-
acquired infection rates in hospitals in




To evaluate the impact of
PR of hospitals as
negative outliers, on PCI






same period of time














After public identification as a negative outlier
institution, there was an 18 % relative
reduction in predicted mortality among PCI































same period of time
Patients of intensive
care units participating











CLABSI mortality There was a reductions in CLABSI rates in the
first 6 months compared with the units in
states with no reporting requirement. During
months 13–18, both state groups with
mandatory PR of CLABSI showed a trend
toward greater reduction in CLABSI compared
with states with no requirement.
Positive
Wang et al., 2014
[45]
To evaluate the effect of
publicly reporting
performance data of
medicine use on the
injection prescribing rate
Cohort study for the
same facility before and
after the introduction














PR led to a reduction of approximately 4 % in
the injection prescribing rate four months
after intervention (OR = 0.96). The intervention
effect was inconsistent in each month after
intervention, and it was most positive in the
second month after intervention (OR = 0.90)
Positive
Yang et al., 2014
[46]
To evaluate the impact of
PR on antibiotic
prescribing for URTI in a






same period of time










PR interventions reduced the incidence of oral
antibiotic prescription (9 % point reduction
adjusted RR = 39 %) and slowed down the
increase of combined use of antibiotics for
URTIs (7 % point reduction (adjusted RR =
36 %), while the use of injectable
antibiotics remained unchanged. The
intervention had little impact on the use of
IV injections or infusions, or the total
prescription expenditure
Mixed
Abbreviations: AMI Acute Myocardial Infarction, CABG Coronary Artery Bypass Graft, CCSIP California Cardiac Surgery and Intervention Project, CHF Congestive Heart Failure, CHQC Cleveland Health Quality Choice,
CLABSI Central Line-Associated BloodStream Infections, NYS CSRS New York State Cardiac Surgery Reporting System, P4P Pay-for-Performance, PCI Percutaneous Coronary Intervention, PHC4 Pennsylvania Health Care
















Effects of public reporting on other clinical outcomes
Other clinical outcomes, beside mortality, were explored
in 8 studies [28, 34, 37, 39, 40, 42, 45, 46]. In an Italian
study performed by Renzi et al. [40], a pre-post evaluation
of clinical outcomes in Lazio Region was done and also a
comparative evaluation versus Italian Regions without
comparable PR programs. The study demonstrated that in
Lazio the PCI within 48 h from admission increased from
22.49 to 29.43 % following the reporting of the Regional
Outcome Evaluation Program (P.Re. Val.E) results. In the
other regions without comparable programs, during the
same period, this proportion increased from 22.48 to
27.09 %. Hip fractures operated on within 48 h from ad-
mission increased in Lazio, while not in other regions with
no PR. Cesarean deliveries did not decrease in Lazio (from
34.57 to 35.30 %), while only slightly decreased in the
other regions (from 30.49 to 28.11 %) [40]. Joynt et al. [39]
reported that after implementation of PR, odds of under-
going PCI in Massachusetts where PR was present de-
creased comparing with non-reporting states (41.1 % vs
Fig. 2 Meta-analysis of the PR effect on mortality as clinical outcome by facilities
Fig. 3 Meta-analysis of the PR effect on different mortality causes as clinical outcomes
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45.6 %; OR = 0.81; 95 % CI = 0.47- 1.38; P = 0.03).
Marsteller et al. [44] in one cohort study on patients from
1,046 adult intensive care units found reductions in central
line-associated bloodstream infections (CLABSIs) rates in
the first 6 months from the release of PR, compared to the
units from the states with no reporting mechanisms. Dur-
ing months 13–18, groups with mandatory PR of data
about CLABSI showed a trend toward greater reduction in
CLABSI compared with states with no PR [44]. Hospital
readmissions were evaluated in two studies. Dranove et al.
[28] reported a negative effect of PR, with a significantly in-
creased average rate of readmissions with heart failure by
approximately 0.5 percentage point. On the other hand,
more recently, Werner et al. [37] reported performance
improvements for AMI in terms of declines in readmission
rates beside lengths-of-stay and mortality rates.
Studies set up outside hospital settings [45, 46] ad-
dressed different clinical outcomes, such as antibiotic pre-
scription and usage as well as injection prescribing rates,
in primary healthcare institutions. Yang et al. [46] evalu-
ated the impact of PR on antibiotic prescribing for upper
respiratory tract infections (URTIs) demonstrating that PR
interventions reduced the incidence of oral antibiotic pre-
scription and slowed down the increase of combined use
of antibiotics for URTIs in primary healthcare setting.
According to Wang et al. [45], PR led to a reduction of
approximately 4 % in the injection prescribing rate four
months after intervention (OR = 0.96; 95 % CI: 0.94, 0.97),
although with an inconsistent effect in each month after
intervention.
Discussion
The public release of hospital performance data has
been recommended as one key strategy for stimulating
improvement of quality of care by putting the focus on
transparency and accountability of healthcare providers.
Also, PR is expected to stimulate active patients/citizens
participation by helping them make informed choices
when choosing health care providers [47].
According to Berwick, PR can improve performance
through 2 pathways. In the Improvement through
Selection pathway, patients and providers could shift
care from low-quality to high-quality hospitals by using
the publicly disclosed reports of hospital performance
quality and thereby stimulating quality improvement
efforts for the benefits of market share. In the Improve-
ment Through Changes in Care (or quality improvement)
pathway, published performance data can identify areas in
which providers had low accomplishment and help them
to focus on improving performance, by appealing to
their professionalism or their concern about reputation
or direct market position. As well, it is more likely that
quality improvement happens in combination of these
two pathways [9].
Nowadays, PR is a more and more common health
policy tool to stimulate and maintain quality improvement
of health care. There is a growing international interest in
providing the necessary information of clinical quality and
performance of healthcare providers [48]. Many studies of
PR performance data have been published so far, but avail-
able reviews of the association between clinical outcomes
and public disclosure of performance data are limited.
In our systematic review on impact of PR on clinical
outcomes, we identified 27 new articles published since
1994. These studies, which were mostly hospital-level
and had medium global ratings, focused primarily on
mortality rates and cardiac procedures. Ten studies
found that mortality rates decreased after PR, while
nine studies did not find a significant link between PR
and improvement.
Most of the studies examined the impact of USA
and Canada PR of mortality rates for cardiac surgery
(CABG and PCI). Different reporting systems were
evaluated across the publications. Many studies that
we found, were focusing their research on the same
group of reporting systems like NYS CSRS which is
considered as a pioneer among PR systems, despite
the fact that nowadays many PR systems are available
on the market [14]. Also studies comparing effectiveness
among different PR systems are lacking. Many studies used
reporting systems based on cardiovascular outcomes, in-
cluding surgical interventions, hospitalization and mortality.
In our review, we found seven studies based on the NYS
CSRS [14, 21, 23, 25, 28, 32, 39], four studies on Cleveland
Health Quality Choice Program (CHQC) [22, 24, 26, 27], as
well as Medicare’s PR initiative [35, 37, 41, 42]. Other
studies used various state-level PR data sources. The
majority of the studies (N = 25) were placed in hos-
pital settings [14, 21–23, 26, 27, 29–38, 40–43], and
two in primary healthcare institutions [45, 46].
As opposed to the studies performed in the hospital set-
ting, little information is available from the literature re-
garding the effectiveness of PR in primary care settings.
Translating knowledge and experience from one health-
care setting to others is a reasonable method for building
the high-quality healthcare service everywhere [49]. Two
studies included in this review [45, 46] demonstrated that
PR can have an impact on medication prescription and
usage in primary healthcare settings. The authors con-
cluded that even though further clinical outcomes of such
an impact were not investigated in their studies, a positive
effect might be expected. To the best of our knowledge,
our review is the first to tackle the effects of PR in primary
care setting, so additional research is still needed to fur-
ther investigate the mechanism by which public reporting
takes effect in outside-hospital settings.
Our research, including 27 studies carried out in
North America, Europe and China, was mainly
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conclusive with the previously published reviews of pub-
lic reports, whereas the effect of the PR on clinical out-
comes was in our qualitative and also, through meta-
analysis technique, quantitative assessment positive for
patients in the hospital setting and primary healthcare
but with a low quality of the evaluated studies. In one of
the first reviews about PR, Marshall et al. [50] showed
improvement in health outcomes among 7 PR systems
based in the USA. In 2008, a systematic review of 11
studies by Fung et al. [5], showed inconsistent associ-
ation between PR and effectiveness on patient outcomes.
They reported that studies of the effect of PR on out-
comes provided mixed signals and that most of the eval-
uated studies were descriptive and had low global
ratings thus limited strength of evidence. They also con-
cluded that PR stimulated quality improvement activity
in hospitals and yet did not affect hospital selection by
patients and generally was limited to a few clinical areas,
like cardiac surgery. In one recent report, Specchia et al.
[51] performed a review on the use of publicly released
performance data and concluded that the introduction
of standard set of evidence based outcomes and per-
formance measures at national level could reduce the
pressure from the selection of performance measures to
be disseminated through the PR and make health care
providers aware of the importance of transparency and
accountability. They also concluded that it would be very
effective to link PR to Pay-for-Performance (P4P) sys-
tems by basing payments on outcome results and
thereby supporting the quality improvement process.
Strengths and limitations
This review has some strengths and limitations. The
comprehensiveness, the focus on clinical outcomes and
the attempt to provide a quantitative synthesis of the
available evidence are strengths of this review. Our
search, in fact, covered a wide time interval and a variety
of settings including both hospitals and primary care in-
stitutions and results has been synthetized both qualita-
tive and, for mortality outcome, quantitative through
meta-analysis technique. However, because of the result-
ing heterogeneity, caution should be placed in interpret-
ing the results of the quantitative synthesis made for
mortality outcome.
Some studies [14, 21, 43] have also noted how, after
the introduction of PR, structures starting from a lower
quality level have a greater propensity to improve their
quality compared to those starting from an already high
level of quality. Difference in starting levels of quality be-
tween the different hospitals and institutions when
introducing PR is also a source of heterogeneity among
the studies included in our review.
Limitations are also present due to the observational
nature of the included studies. Indeed, the studies which
control and study cohorts were taken from the same fa-
cilities before and after the introduction of a PR mech-
anism may have overestimated the effect of PR, because
of a technological improvement trend running parallel
to the adoption of the PR [41].
Search strategy was also limited to English language
studies published from 1991 and most of published evi-
dence concern cardiovascular disease in hospital setting.
Policy implications
PR can be considered as one of the key drivers for trans-
parency and accountability in the public health field. Far
from providing a quantitative estimate of the current use
of PR, the experiences described in this paper can repre-
sent a framework of opportunities for changing the rela-
tionship between patients/customers and healthcare
providers and as a tool to support policy makers in ad-
dressing and allocating resources according to the as-
sessment of providers’ performances and the publication
of their results which are accessible and understandable
to all of the stakeholders, including patients/customers.
Several successful examples of stakeholder involvement
in the processes deriving from PR have been described
both in the United States [50] and in Europe, as in
Netherlands [52] or Germany [53]. In particular WHO
Regional Office for Europe suggested key considerations
for a successful strategy to encourage providers in improv-
ing the quality of services, the accountability of processes,
the identification of failures, and providing with the use of
publicly reported quality information strengthening com-
munication tools, supporting public health professionals
and making clearer consequent decisions [54].
The decision-making is always a difficult process for
patients. To obtain informed choices high levels of nu-
meracy and literacy are needed and PR can be consid-
ered a useful instrument to face this issue. Therefore,
policy makers should support good practices in Public
Health especially those, such as PR, focused on in-
creased patient awareness.
Moreover, health policies should be promoted with the
aim to integrate different strategies pursuing quality and
excellence in healthcare. For example, linking PR to P4P,
and therefore to remuneration for incentives schemes
based on performance data, would strengthen the com-
petitiveness of the whole system, triggering at the same
time a virtuous circle oriented to the increase of both
appropriateness and continuous quality improvement of
healthcare [51].
Conclusions
The introduction of PR programs at different levels of
the healthcare sector is a challenging but rewarding pub-
lic health strategy. Existing research covering different
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clinical outcomes supports the idea that PR could, in
fact, stimulate providers to improve healthcare quality.
Transparency and accountability resulting from PR im-
plementation not only give patients those information
tools customers commonly are able to access in many
other sectors, but are key points in the process that make
patients and citizens empowered protagonist of their care.
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